Cargando…

Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study

BACKGROUND: Residential treatment is a common approach for treating opioid use disorder (OUD), however, few studies have directly compared it to outpatient treatment. The objective of this study was to compare OUD outcomes among individuals receiving residential and outpatient treatment. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartung, Daniel M., Markwardt, Sheila, Johnston, Kirbee, Geddes, Jonah, Baker, Robin, Leichtling, Gillian, Hildebran, Christi, Chan, Brian, Cook, Ryan R., McCarty, Dennis, Ghitza, Udi, Korthuis, P. Todd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389731/ https://www.ncbi.nlm.nih.gov/pubmed/35986384 http://dx.doi.org/10.1186/s13722-022-00318-1

Ejemplares similares

Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptions
por: Hartung, Daniel M., et al.
Publicado: (2022)

Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis
por: McCarty, Dennis, et al.
Publicado: (2019)

Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19
por: Seaman, Andrew, et al.
Publicado: (2021)

The impact of CARA mandates on nurse practitioner controlled substance prescribing in Oregon: a cohort study
por: Klein, Tracy A., et al.
Publicado: (2022)

“It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply
por: Shin, Sarah S., et al.
Publicado: (2022)

Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication
por: McIlveen, John W., et al.
Publicado: (2021)

Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities
por: McCarty, Dennis, et al.
Publicado: (2017)

Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain: Clinical Implications
por: Ghitza, Udi E.
Publicado: (2016)

State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees
por: Lindner, Stephan R., et al.
Publicado: (2023)

Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial
por: Hoffman, Kim A., et al.
Publicado: (2019)

Reducing overdose after release from incarceration (ROAR): study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison
por: Waddell, Elizabeth Needham, et al.
Publicado: (2020)

Collaboration Between Oregon’s Chronic Disease Programs and Medicaid to Decrease Smoking Among Medicaid-Insured Oregonians With Asthma
por: Rebanal, R. David, et al.
Publicado: (2005)

The opioid overdose epidemic: opportunities for pharmacists
por: Wu, Li-Tzy, et al.
Publicado: (2017)

A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the “peer tele-HCV” study
por: Herink, Megan C., et al.
Publicado: (2023)

Estimating Demand for Care After a Medicaid Expansion: Lessons From Oregon
por: Gold, Rachel, et al.
Publicado: (2014)

Covering Uninsured Adults Through Medicaid: Lessons from the Oregon Health Plan
por: Haber, Susan G., et al.
Publicado: (2000)

Association of Implementing an Incentive Metric in the Oregon Medicaid Program With Effective Contraceptive Use
por: Rodriguez, Maria I., et al.
Publicado: (2020)

Opioid Prescribing Patterns by Naturopathic Physicians in Oregon
por: Bradley, Ryan, et al.
Publicado: (2019)

Postpartum Medicaid coverage and outpatient care utilization among low-income birthing individuals in Oregon: impact of Medicaid expansion
por: Pradhan, Satyasandipani, et al.
Publicado: (2023)

Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: an interrupted time series analysis
por: Herink, Megan C, et al.
Publicado: (2021)

Tobacco use by pregnant Medicaid beneficiaries: Validating a claims-based measure in Oregon
por: Luck, Jeff, et al.
Publicado: (2020)

Preventing deaths from rising opioid overdose in the US – the promise of naloxone antidote in community-based naloxone take-home programs
por: Straus, Michele M, et al.
Publicado: (2013)

Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
por: Hoffman, Kim A., et al.
Publicado: (2021)

Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis
por: Hoffman, Kim A., et al.
Publicado: (2022)

Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis
por: Levander, Ximena A., et al.
Publicado: (2021)

Reducing Tobacco Use in Oregon Through Multisector Collaboration: Aligning Medicaid and Public Health Programs
por: Livingston, Catherine J., et al.
Publicado: (2020)

Medicaid expansion in Oregon and postpartum healthcare among people with and without prenatal substance use disorder()
por: Haight, Sarah C., et al.
Publicado: (2022)

Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities
por: Korthuis, P. Todd, et al.
Publicado: (2022)

Oregon
Publicado: (1896)

Oregon
Publicado: (1897)

A Commentary on “A New Initiative on Precision Medicine”
por: Ghitza, Udi E.
Publicado: (2015)

Commentary: A Gene-Based Association Method for Mapping Traits Using Reference Transcriptome Data
por: Ghitza, Udi E.
Publicado: (2016)

Commentary: Rewriting the Valuation and Salience of Alcohol-Related Stimuli via Memory Reconsolidation
por: Ghitza, Udi E.
Publicado: (2016)

ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine Framework
por: Ghitza, Udi E.
Publicado: (2014)

Needed Relapse-Prevention Research on Novel Framework (ASPIRE Model) for Substance Use Disorders Treatment
por: Ghitza, Udi E.
Publicado: (2015)

Commentary: Interaction of the ADRB2 Gene Polymorphism with Childhood Trauma in Predicting Adult Symptoms of Posttraumatic Stress Disorder
por: Ghitza, Udi E.
Publicado: (2015)

Commentary: Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders
por: Ghitza, Udi E.
Publicado: (2017)

The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities
por: Stack, Erin, et al.
Publicado: (2021)

Concomitant Cannabis Misuse and Associations with Depression, Pain and Substance Misuse among Patients Prescribed Opioids
por: Bryan, M. Aryana, et al.
Publicado: (2021)

Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018
por: Capizzi, Jeffrey, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m7l9sm778a9ovjnervqnqjv1la